Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-11, Stock:PFE, The news for the past five days is as follows:
2018-10-04: NEWS1: Top Performing ETFs of the Third Quarter.NEWS2: Top Performing ETFs of the Third Quarter.NEWS3: What AbbVie’s Valuation Trend Indicates.NEWS4: Seattle Genetics: Impact of the Cascadian Acquisition.NEWS5: Antares Pharma Is Expected to Report Positive EPS in 2019.NEWS6: 5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock.NEWS7: 5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock.NEWS8: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS9: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS10: Amgen’s Stock Performance and Estimates after Q3 2018.NEWS11: 5 Reasons Why Investors Should Bet on Pfizer (PFE) Stock.NEWS12: Better Buy: Gilead Sciences, Inc. vs. Pfizer.NEWS13: Better Buy: Gilead Sciences, Inc. vs. Pfizer.NEWS14: Better Buy: Gilead Sciences, Inc. vs. Pfizer.NEWS15: How Did Pfizer Stock Fare in Q3 2018?.NEWS16: Eli Lilly’s Stock Performance and Estimates for Q3 2018.NEWS17: Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US.
2018-10-05: NEWS1: Dow Tumbles 180 Points to End Lower for the Week.NEWS2: Dow Tumbles 180 Points to End Lower for the Week.NEWS3: Johnson & Johnson Stock in the Week Ended October 5.NEWS4: Market Close Report: NASDAQ Composite index closes at 7,788.45 down -91.06 points.NEWS5: Market Close Report: NASDAQ Composite index closes at 7,788.45 down -91.06 points.NEWS6: Gilead Sciences: What to Expect from the Top Line.NEWS7: How’s Gilead Sciences Positioned in October?.NEWS8: Rising Yields Pose Risk to Large-Cap Pharma&apos;s Red-Hot Rally.NEWS9: Dow 30 Stock Roundup: Boeing Wins $9.2B Pilot Training Deal, Intel Keeps '18 View.NEWS10: Dow 30 Stock Roundup: Boeing Wins $9.2B Pilot Training Deal, Intel Keeps '18 View.NEWS11: Pharma Stock Roundup: PFE to Get New CEO, LLY Presents Impressive Diabetes Data.NEWS12: Health Care Sector Update for 10/05/2018: JNJ, PFE, ABT, MRK, AMGN, HSGX, KMPH.NEWS13: Health Care Sector Update for 10/05/2018: JNJ, PFE, ABT, MRK, AMGN, HSGX, KMPH.NEWS14: Dow 30 Stock Roundup: Boeing Wins $9.2B Pilot Training Deal, Intel Keeps &apos;18 View.NEWS15: What Seattle Genetics’ Valuation Trend Indicates.NEWS16: Sangamo Therapeutics: Analysts Expect 88% Upside Potential.
2018-10-08: NEWS1: Dow Rallies Back, S&P 500 Retakes Key Support As Tech Stocks Fall.NEWS2: Top Stock Reports for Apple, Microsoft & Pfizer.NEWS3: Top Stock Reports for Apple, Microsoft & Pfizer.NEWS4: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS5: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS6: Top Stock Reports for Apple, Microsoft & Pfizer.NEWS7: The Uphill Fight Against Fake Prescription Drugs.NEWS8: Health Care Digest: Upsized record IPO, e-cigarette questions, a CEO Dance and more.NEWS9: PFE Crosses Above Average Analyst Target.NEWS10: PFE Crosses Above Average Analyst Target.NEWS11: Johnson & Johnson’s Valuation Trend in October.NEWS12: Gilead Sciences Stock: Analysts’ Recommendations.NEWS13: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS14: How Much Upside Potential Do Analysts See in JNJ Stock?.NEWS15: Pfizer May Rise 8% to Highest Price Since 2000.NEWS16: AP FACT CHECK: Trump fudges history on black vote, drug cost.NEWS17: AP FACT CHECK: Trump fudges history on black vote, drug cost.
2018-10-09: NEWS1: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS2: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS3: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS4: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?.NEWS5: [$$] Pfizer Prepares for CEO Transition With Executive Suite Changes.NEWS6: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS8: The Zacks Analyst Blog Highlights: Apple, Microsoft, Pfizer, Caterpillar and ConocoPhillips.NEWS9: The Zacks Analyst Blog Highlights: Apple, Microsoft, Pfizer, Caterpillar and ConocoPhillips.NEWS10: Pfizer Announces Executive Leadership Team.NEWS11: The Zacks Analyst Blog Highlights: Apple, Microsoft, Pfizer, Caterpillar and ConocoPhillips.NEWS12: Pfizer Announces New Executive Team - Quick Facts.NEWS13: Pfizer Announces New Executive Team - Quick Facts.NEWS14: Myriad Signs Commercialization Plan With Pfizer - Quick Facts.NEWS15: Myriad Signs Commercialization Plan With Pfizer - Quick Facts.
2018-10-10: NEWS1: Could Johnson & Johnson Meet Its Q3 2018 Sales Estimates?.NEWS2: Analysts’ Ratings for Johnson & Johnson before Its Q3 Earnings.NEWS3: Health Care Sector Update for 10/10/2018: NVCN,MYGN,PFE,IGC,AKRX.NEWS4: Health Care Sector Update for 10/10/2018: NVCN,MYGN,PFE,IGC,AKRX.NEWS5: Pfizer (PFE) Shares Cross 3% Yield Mark.NEWS6: Pfizer (PFE) Shares Cross 3% Yield Mark.NEWS7: Alexion Pharmaceuticals’ Operational Performance.NEWS8: Analyzing Alexion Pharmaceuticals’ Top-Line Trends.NEWS9: How Alexion Pharmaceuticals Is Positioned in October.NEWS10: Health Care Sector Update for 10/10/2018: MYGN,PFE,IGC,RARX,AKRX.NEWS11: Health Care Sector Update for 10/10/2018: MYGN,PFE,IGC,RARX,AKRX.NEWS12: Final trades: Verizon, EOG Resources, Arconic & Pfizer.NEWS13: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS14: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS15: How Bristol-Myers Squibb’s Valuation Metrics Look in October.NEWS16: MARKETS: Stocks at the Rubicon, as Intel leads the Dow lower, but Merck, Pfizer at 17-year highs.NEWS17: Myriad Genetics shares soar 7% on news it will conduct testing for Pfizer breast cancer treatment.NEWS18: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS19: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS20: What Bristol-Myers Squibb’s Operational Performance Indicates.NEWS21: Why Pfizer Stock Is Likely Seeing Big Buying.NEWS22: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS23: The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares.NEWS24: Myriad Genetics Inc. (MYGN) Is Climbing On Pfizer Deal.NEWS25: Myriad Genetics Inc. (MYGN) Is Climbing On Pfizer Deal.

Answer: Decrease